In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s – Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval…and it’s probably not what you think! A quick, but useful listen.

Listen in and let us know what you think!